Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Ra Capital Management LP | Director | 2023-12-11 | 1,000,000 | $5.00 | $5.00MBuy |
Ra Capital Management LP | Director | 2023-12-11 | 1,000,000 | $5.00 | $5.00MBuy |
Gsk PLC | 10% Owner | 2023-12-07 | 3,300,000 | $5.00 | $16.50MBuy |
Kyle Moran | Chief Financial Officer | 2023-08-23 | 37,062 | $4.75 | $176.12kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Ra Capital Management LP | 21.08% | 25,775,622 | $145.89M | Insider |
Gsk PLC | 20.17% | 24,667,522 | $139.62M | Insider |
Ra Capital Management LP | 14.89% | 18,202,009 | $103.02M | Institution |
Maverick Capital Ltd | 6.91% | 8,447,804 | $47.81M | Institution |
M28 Capital Management LP | 6.03% | 7,373,413 | $41.73M | Institution |
Adage Capital Partners GP LLC | 4.90% | 5,987,730 | $33.89M | Institution |
683 Capital Management LLC | 4.58% | 5,600,000 | $31.70M | Institution |
Blackrock Inc | 4.39% | 5,366,288 | $30.37M | Institution |
Bellevue Group Ag | 3.68% | 4,494,458 | $25.44M | Institution |
Kynam Capital Management LP | 3.22% | 3,932,082 | $22.26M | Institution |